Literature DB >> 16720432

Restenosis related to percutaneous coronary intervention has been solved?

Antti Kivelä1, Juha Hartikainen.   

Abstract

Percutaneous coronary intervention (PCI) has become the most important revascularization method in the treatment of coronary artery disease. The major problem in PCI has been renarrowing of the dilated vessel after the procedure (restenosis). The best results in the prevention of restenosis have been obtained by covering the stent with drugs that inhibit cellular growth, thus limiting excessive scar formation inside of the stent. With drug-eluting stents, restenosis has been reduced to one-tenth compared with balloon angioplasty and to one-fourth compared to bare metal stents. Due to drug-eluting stents, PCI is an alternative to bypass surgery. However, restenosis will remain a challenge due to the increased number of procedures and more difficult disease treated with PCI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720432     DOI: 10.1080/07853890600643404

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  3 in total

Review 1.  Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.

Authors:  Jun Chen; Haoyu Meng; Lei Xu; Jie Liu; Deyu Kong; Pengsheng Chen; Xiaoxuan Gong; Jianling Bai; Fengwei Zou; Zhijian Yang; Chunjian Li; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

2.  Urotensin-II Immunoreactivity in Normolipidemic and Hyperlipidemic New Zealand White Rabbits Following Balloon Angioplasty and Stenting.

Authors:  Nicolas Bousette; Fazila Chouiali; Eliot H Ohlstein; Stephen A Douglas; Adel Giaid
Journal:  Int J Biomed Sci       Date:  2007-03

3.  Dextran grafting on PTFE surface for cardiovascular applications.

Authors:  Eléonore C Michel; Vanessa Montaño-Machado; Pascale Chevallier; Amélie Labbé-Barrère; Didier Letourneur; Diego Mantovani
Journal:  Biomatter       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.